Drug Safety

Is There Still a Role for Aprotinin in Cardiac Surgery?
pp. 731-740(10)
Authors: Sodha, Neel R.; Boodhwani, Munir; Sellke, Frank W.

Thiazolidinediones and their Fluid-Related Adverse Effects: Facts, Fiction and Putative Management Strategies
pp. 741-753(13)
Authors: Karalliedde, Janaka; Buckingham, Robin E.

Safety Considerations with Bisphosphonates for the Treatment of Osteoporosis
pp. 755-763(9)
Authors: Strampel, William; Emkey, Ronald; Civitelli, Roberto

Benefit-Risk Assessment of Nesiritide in the Treatment of Acute Decompensated Heart Failure
pp. 765-781(17)
Author: Yancy, Clyde W.

Drug-Induced Cardiovascular Disorders
pp. 783-804(22)
Authors: Murphy, C. Aengus; Dargie, Henry J.

Clinical Pattern of Zileuton-Associated Liver Injury: Results of a 12-Month Study in Patients with Chronic Asthma
pp. 805-815(11)
Authors: Watkins, Paul B.; Dube, Louise M.; Walton-Bowen, Karen; Cameron, Christopher M.; Kasten, Linda E.

Adverse Drug Event Detection in a Community Hospital Utilising Computerised Medication and Laboratory Data
pp. 817-824(8)
Authors: Seger, Andrew C.; Jha, Ashish K.; Bates, David W.